205 related articles for article (PubMed ID: 27233261)
21. Characterization of antibody response in patients with acute and chronic chikungunya virus disease.
Anfasa F; Lim SM; Fekken S; Wever R; Osterhaus ADME; Martina BEE
J Clin Virol; 2019 Aug; 117():68-72. PubMed ID: 31229935
[TBL] [Abstract][Full Text] [Related]
22. Development and evaluation of baculovirus-expressed Chikungunya virus E1 envelope proteins for serodiagnosis of Chikungunya infection.
Kumar P; Pok KY; Tan LK; Angela C; Leo YS; Ng LC
J Virol Methods; 2014 Sep; 206():67-75. PubMed ID: 24880071
[TBL] [Abstract][Full Text] [Related]
23. Development of Neutralization Assay Using an eGFP Chikungunya Virus.
Deng CL; Liu SQ; Zhou DG; Xu LL; Li XD; Zhang PT; Li PH; Ye HQ; Wei HP; Yuan ZM; Qin CF; Zhang B
Viruses; 2016 Jun; 8(7):. PubMed ID: 27367716
[TBL] [Abstract][Full Text] [Related]
24. Comparative evaluation of the diagnostic potential of recombinant envelope proteins and native cell culture purified viral antigens of Chikungunya virus.
Khan M; Dhanwani R; Kumar JS; Rao PV; Parida M
J Med Virol; 2014 Jul; 86(7):1169-75. PubMed ID: 24105844
[TBL] [Abstract][Full Text] [Related]
25. Evaluation of multiple antigenic peptides based on the Chikungunya E2 protein for improved serological diagnosis of infection.
Bhatnagar S; Kumar P; Mohan T; Verma P; Parida MM; Hoti SL; Rao DN
Viral Immunol; 2015 Mar; 28(2):107-12. PubMed ID: 25412351
[TBL] [Abstract][Full Text] [Related]
26. Development of a Specific CHIKV-E2 Monoclonal Antibody for Chikungunya Diagnosis.
Kim J; Yang J; Kim YB; Lee HJ; Kim S; Poo H
Virol Sin; 2019 Oct; 34(5):563-571. PubMed ID: 31214999
[TBL] [Abstract][Full Text] [Related]
27. A small antigenic determinant of the Chikungunya virus E2 protein is sufficient to induce neutralizing antibodies which are partially protective in mice.
Weber C; Büchner SM; Schnierle BS
PLoS Negl Trop Dis; 2015 Apr; 9(4):e0003684. PubMed ID: 25905779
[TBL] [Abstract][Full Text] [Related]
28. Development and Evaluation of an in-House IgM-Capture ELISA for the Detection of Chikungunya and Its Application to a Dengue Outbreak Situation in Kenya in 2013.
Wasonga C; Inoue S; Kimotho J; Morita K; Ongus J; Sang R; Musila L
Jpn J Infect Dis; 2015; 68(5):410-4. PubMed ID: 25866119
[TBL] [Abstract][Full Text] [Related]
29. Evidence of Chikungunya virus circulation in the Terai region of Nepal in 2014 and 2015.
Pandey K; Pandey BD; Chaurasiya RR; Thakur M; Neupane B; Shah Y; Ngwe Tun MM; Morita K
Trans R Soc Trop Med Hyg; 2017 Jul; 111(7):294-299. PubMed ID: 29165625
[TBL] [Abstract][Full Text] [Related]
30. A DNA vaccine against chikungunya virus is protective in mice and induces neutralizing antibodies in mice and nonhuman primates.
Mallilankaraman K; Shedlock DJ; Bao H; Kawalekar OU; Fagone P; Ramanathan AA; Ferraro B; Stabenow J; Vijayachari P; Sundaram SG; Muruganandam N; Sarangan G; Srikanth P; Khan AS; Lewis MG; Kim JJ; Sardesai NY; Muthumani K; Weiner DB
PLoS Negl Trop Dis; 2011 Jan; 5(1):e928. PubMed ID: 21264351
[TBL] [Abstract][Full Text] [Related]
31. Diagnostic potential of monoclonal antibodies against the capsid protein of chikungunya virus for detection of recent infection.
Damle RG; Jayaram N; Kulkarni SM; Nigade K; Khutwad K; Gosavi S; Parashar D
Arch Virol; 2016 Jun; 161(6):1611-22. PubMed ID: 27016930
[TBL] [Abstract][Full Text] [Related]
32. Chikungunya Virus Seroprevalence and Associated Factors among Hospital Attendees in Two States of Southwest Nigeria: A Preliminary Assessment.
Olajiga OM; Adesoye OE; Emilolorun AP; Adeyemi AJ; Adeyefa EO; Aderibigbe IA; Adejumo SA; Adebimpe WO; Opaleye OO; Sule WF; Oluwayelu DO
Immunol Invest; 2017 Aug; 46(6):552-565. PubMed ID: 28742401
[TBL] [Abstract][Full Text] [Related]
33. Chikungunya E2 Protein Produced in
Bagno FF; Godói LC; Figueiredo MM; Sérgio SAR; Moraes TFS; Salazar NC; Kim YC; Reyes-Sandoval A; da Fonseca FG
Viruses; 2020 Aug; 12(9):. PubMed ID: 32858804
[TBL] [Abstract][Full Text] [Related]
34. No chikungunya virus infections among Dutch long-term travellers to (sub)tropical countries: a prospective study 2008-2011.
Overbosch FW; Elfrink F; Schinkel J; Sonder GJB
BMC Infect Dis; 2019 Feb; 19(1):196. PubMed ID: 30808283
[TBL] [Abstract][Full Text] [Related]
35. Monoclonal Antibodies as Prophylactic and Therapeutic Agents Against Chikungunya Virus.
Clayton AM
J Infect Dis; 2016 Dec; 214(suppl 5):S506-S509. PubMed ID: 27920182
[TBL] [Abstract][Full Text] [Related]
36. Development of Vaccines for Chikungunya Fever.
Erasmus JH; Rossi SL; Weaver SC
J Infect Dis; 2016 Dec; 214(suppl 5):S488-S496. PubMed ID: 27920179
[TBL] [Abstract][Full Text] [Related]
37. Robustness of Serologic Investigations for Chikungunya and Mayaro Viruses following Coemergence.
Fischer C; Bozza F; Merino Merino XJ; Pedroso C; de Oliveira Filho EF; Moreira-Soto A; Schwalb A; de Lamballerie X; Netto EM; Bozza PT; Sarno M; Brites C; Gotuzzo E; Talledo M; Drexler JF
mSphere; 2020 Feb; 5(1):. PubMed ID: 32024703
[TBL] [Abstract][Full Text] [Related]
38. A sensitive epitope-blocking ELISA for the detection of Chikungunya virus-specific antibodies in patients.
Goh LY; Kam YW; Metz SW; Hobson-Peters J; Prow NA; McCarthy S; Smith DW; Pijlman GP; Ng LF; Hall RA
J Virol Methods; 2015 Sep; 222():55-61. PubMed ID: 26025459
[TBL] [Abstract][Full Text] [Related]
39. Cloning, expression and evaluation of diagnostic potential of recombinant capsid protein based IgM ELISA for chikungunya virus.
Priya R; Khan M; Rao MK; Parida M
J Virol Methods; 2014 Jul; 203():15-22. PubMed ID: 24681089
[TBL] [Abstract][Full Text] [Related]
40. [[Virus-like particle-based immunoglobulin M capture enzyme-linked immunosorbent assay for the detection of IgM antibodies against Chikungunya virus].
Li JD; Zhang QF; Zhang S; Li C; Liu QZ; Liang MF; Li DX
Bing Du Xue Bao; 2014 Nov; 30(6):599-604. PubMed ID: 25868272
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
